Jasper Therapeutics Inc (JSPR) Live Share Price, Invest From India

Jasper Therapeutics Inc Stock Performance

as on October 18, 2025 at 1:29 am IST

Day's Low
Day's High
$2.4
Day's Price Range
$2.51
$2.46
2.44%
Downside
2.03%
Upside
52 Week's Low
52 Week's High
$2.22
52-Week Price Range
$26.05
$2.46
9.96%
Downside
958.94%
Upside

Jasper Therapeutics Inc share price movements today

Previous Close: $2.48
Open: $2.47
Volume: 446.0K
Day's Low - High: $2.4 - $2.51
52 Week Low - High: $2.22 - $26.05

Jasper Therapeutics Inc Historical Returns

1 Month Return: -2 %
3 Month Return: -26.43 %
1 Year Return: -87.77 %
3 Year Return: -66.89 %
5 Year Return: 0 %

Jasper Therapeutics Inc Stock Fundamentals & Key Indicators

Check Jasper Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$68.4M

EPS (TTM)

-4.8145

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-92.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

151937600.00%

Jasper Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jasper Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Jasper Therapeutics Inc	BUY	$68.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$63.1B	240.52%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.3B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$106.9B	94.28%	29.67	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	0.25%	14.58	31.37%

Stock Returns calculator for Jasper Therapeutics Inc Stock including INR - Dollar returns

The Jasper Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Jasper Therapeutics Inc investment value today

Current value as on today

₹17,070

Returns

₹82,930

(-82.93%)

Returns from Jasper Therapeutics Inc Stock

₹87,725 (-87.72%)

Dollar Returns*

₹4,794 (+4.79%)

Analyst Recommendation on Jasper Therapeutics Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Jasper Therapeutics Inc. Average target price of $18.29

Jasper Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Jasper Therapeutics Inc.

What analysts predicted

86.55%UPSIDE

Target Price

$18.29

Current Price

$2.46

Analyzed by

13 Analysts

Target

$18.29

Jasper Therapeutics Inc target price $18.29, a slight upside of 86.55% compared to current price of $2.46. According to 13 analysts rating.

Jasper Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Jasper Therapeutics Inc Stock has increased by 171% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 20, 2025 to October 20, 2025

Change:171% versus previous 30 day period

Jasper Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	1	-	2	-	-	-	1	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-13	-17	-19	-17	-15	-15	-19	-25	-21	-27
EBITDA	-13	-17	-19	-17	-14	-15	-19	-21	-21	-27
Interest Expense	0	-	-	0	-	-	-	5	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-16	-17	-16	-13	-14	-18	-24	-21	-26
Income Tax Expense	1	-1	-1	1	0	0	-	0	-	-
Net Income	-14	-16	-17	-16	-13	-14	-18	-24	-21	-26
Net Profit Margin	4555.91%	-920.44%	0.00%	-808.04%	0.00%	0.00%	0.00%	-2071.64%	0.00%	0.00%

Jasper Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	6	13	-	-
Gross Profit	0	0	-1	-1	-1
Operating Income	-20	-36	-51	-68	-77
EBITDA	-31	-36	-50	-64	-71
Interest Expense	10	6	13	-	-
Depreciation	-	0	0	1	1
Income Before Tax	-31	-30	-37	-66	-72
Income Tax Expense	0	-1	-13	-1	-1
Net Income	-31	-30	-37	-64	-71
Net Profit Margin	0.00%	-494.46%	-278.92%	0.00%	0.00%

Jasper Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-16	-17	-16	-13	-14	-18	-24	-21	-44
Operating Cash Flow	-13	-11	-16	-15	-11	-14	-21	-22	-15
Investing Cash Flow	0	-	0	0	0	0	0	0	0
Financing Cash Flow	0	0	0	47	0	0	0	-	6
Change in Cash	-13	-11	-16	31	-11	-14	-20	-22	-9

Jasper Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-31	-30	-37	-64	-71
Operating Cash Flow	-18	-33	-45	-52	-62
Investing Cash Flow	0	-2	0	0	0
Financing Cash Flow	11	100	0	100	47
Change in Cash	-6	64	-46	48	-15

Global Institutional Holdings in Jasper Therapeutics Inc

Funds	Holdings
Soleus Capital Management, L.P.	9.19%
Velan Capital Investment Management LP	8.82%
The Carlyle Group Inc	6.56%
Qiming U.S. Ventures Management, LLC	5.72%
Morgan Stanley - Brokerage Accounts	4.74%

See all

Insights on Jasper Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 150.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 149.6% return, outperforming this stock by 216.5%
NEGATIVE IMPACT
Price Dip
In the last 6 months, JSPR stock has moved down by -38.3%

About Jasper Therapeutics Inc

jasper therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. jasper’s lead compound, jsp191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.

Organisation	Jasper Therapeutics Inc
Headquarters	2200 Bridge Pkwy, Redwood City, CA, United States, 94065
CEO	Mr. Ronald A. Martell
E-voting on shares	Click here to vote

Key Management of Jasper Therapeutics Inc

Name	Title
Ms. Patricia Carlos	Senior Vice President of Regulatory Affairs & Quality
Mr. Matthew Ford	Senior Vice President of Human Resources
Dr. Daniel C. Adelman M.D.	Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor
Mr. Herbert C. Cross CPA	CFO & Corporate Secretary
Mr. Jeetinder Singh Mahal M.B.A.	Chief Operating Officer
Dr. Wendy Pang M.D., Ph.D.	Senior Vice President of Research & Translational Medicine
Dr. Luca Di Noto Ph.D.	Senior Vice President of Technical Operations
Ms. Kimberly Baxter	VP & Head of Quality
Mr. Ronald A. Martell	President, CEO & Director
Dr. Judith Anne Shizuru M.D., Ph.D.	Co-Founder, Member of Scientific Advisory Board & Director

FAQs

What is Jasper Therapeutics Inc share price today?

Jasper Therapeutics Inc share price today is $2.46 as on October 18, 2025 at 1:29 am IST at the close of the market. Jasper Therapeutics Inc share today touched a day high of $2.51 and a low of $2.4.

What is the 52 week high and 52 week low for Jasper Therapeutics Inc share?

Jasper Therapeutics Inc share touched a 52 week high of $26.05 on December 3, 2024 and a 52 week low of $2.22 on September 25, 2025. Jasper Therapeutics Inc stock price today i.e. October 18, 2025 at 1:29 am IST is closed at $2.46,which is 90.56% down from its 52 week high and 11.06% up from its 52 week low.

What is Jasper Therapeutics Inc's market capitalisation today?

Jasper Therapeutics Inc market capitalisation is $0.00T as on October 18, 2025 at 1:29 am IST.

How to invest in Jasper Therapeutics Inc Stock (JSPR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Jasper Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jasper Therapeutics Inc Shares that will get you 0.6098 shares as per Jasper Therapeutics Inc share price of $2.46 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jasper Therapeutics Inc Stock (JSPR) from India?

Indian investors can start investing in Jasper Therapeutics Inc (JSPR) shares with as little as ₹87.954 or $1 (as of October 20, 2025 at 10:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Jasper Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 20, 2025 at 10:42 am IST). Based on Jasper Therapeutics Inc share’s latest price of $2.46 as on October 18, 2025 at 1:29 am IST, you will get 4.0650 shares of Jasper Therapeutics Inc. Learn more about fractional shares .